Loading…

Repeat Cytoreductive Surgery with or Without Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy

Abstract Background A significant proportion of patients with peritoneal surface malignancy (PSM) experienced recurrence after initial cytoreductive surgery (CRS). Thus the aims of this study were to determine short-term outcomes and long-term survivals associated with repeat CRS. Methods This was a...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of surgery 2017-06, Vol.213 (6), p.1024-1030
Main Authors: Huang, Yeqian, BMed, MD, Alzahrani, Nayef A., MBBS, Chua, Terence C., MBBS, PhD, MRCS (Ed), Liauw, Winston, MBBS, M Med Sci, Morris, David L., MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background A significant proportion of patients with peritoneal surface malignancy (PSM) experienced recurrence after initial cytoreductive surgery (CRS). Thus the aims of this study were to determine short-term outcomes and long-term survivals associated with repeat CRS. Methods This was a retrospective study of prospectively collected data of consecutive patients with PSM who underwent CRS by one surgical team at St George Hospital in Sydney, Australia between Jan 1996 and May 2016. Results There was no significant difference in hospital mortality (p=0.343) and major morbidity rate (p=0.454). Patients who underwent repeat surgery had a significantly higher 5-year overall survival (OS) rate (p
ISSN:0002-9610
1879-1883
DOI:10.1016/j.amjsurg.2016.09.046